Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago

Ce, Ezenwaka; Dimgba, A; Okali, F; Skinner, Timothy C.; Extavour, Rian Marie; Rodriguez, Mario; A, Jones-Lecointe

doi:10.4103/1119-3077.79230

Cited by 11 publications

(13 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies and systematic reviews have found that the prevalence of HBsAg among pregnant women in a collection of African nations varies from 2.4–16% [ 11 ]. For example, a study conducted among Sudanese pregnant women found a prevalence of 5.6%; [ 12 ] similar studies estimated a prevalence of 8.2% in Nigeria [ 13 ], 6.3% in Tanzania [ 14 ], 8.0% in Mali [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

Hepatitis B virus and HIV co-infection among pregnant women in Rwanda

Mutagoma

Balisanga

Malamba³

et al. 2017

BMC Infect Dis

View full text Add to dashboard Cite

BackgroundHepatitis B virus (HBV) affects people worldwide but the local burden especially in pregnant women and their new born babies is unknown. In Rwanda HIV-infected individuals who are also infected with HBV are supposed to be initiated on ART immediately. HBV is easily transmitted from mother to child during delivery. We sought to estimate the prevalence of chronic HBV infection among pregnant women attending ante-natal clinic (ANC) in Rwanda and to determine factors associated with HBV and HIV co-infection.MethodsThis study used a cross-sectional survey, targeting pregnant women in sentinel sites. Pregnant women were tested for hepatitis B surface antigen (HBsAg) and HIV infection. A series of tests were done to ensure high sensitivity. Multivariable logistic regression was used to identify independent predictors of HBV-HIV co-infection among those collected during ANC sentinel surveillance, these included: age, marital status, education level, occupation, residence, pregnancy and syphilis infection.ResultsThe prevalence of HBsAg among 13,121 pregnant women was 3.7% (95% CI: 3.4–4.0%) and was similar among different socio-demographic characteristics that were assessed. The proportion of HIV-infection among HBsAg-positive pregnant women was 4.1% [95% CI: 2.5–6.3%]. The prevalence of HBV-HIV co-infection was higher among women aged 15-24 years compared to those women aged 25–49 years [aOR = 6.9 (95% CI: 1.8–27.0)]. Women residing in urban areas seemed having HBV-HIV co-infection compared with women residing in rural areas [aOR = 4.3 (95% CI: 1.2–16.4)]. Women with more than two pregnancies were potentially having the co-infection compared to those with two or less (aOR = 6.9 (95% CI: 1.7–27.8). Women with RPR-positive test were seemed associated with HBV-HIV co-infection (aOR = 24.9 (95% CI: 5.0–122.9).ConclusionChronic HBV infection is a public health problem among pregnant women in Rwanda. Understanding that HBV-HIV co-infection may be more prominent in younger women from urban residences will help inform and strengthen HBV prevention and treatment programmes among HIV-infected pregnant women, which is crucial to this population.

show abstract

Section: Introductionmentioning

confidence: 99%

Hepatitis B virus and HIV co-infection among pregnant women in Rwanda

Mutagoma

Balisanga

Malamba³

et al. 2017

BMC Infect Dis

View full text Add to dashboard Cite

show abstract

“…50 The retrospective observational ROSSO study found that SMBG was associated with reduced incidence of micro-and macrovascular events and all-cause mortality, irrespective of insulin use. [51][52][53] On the other hand, longitudinal observational data from the Fremantle Diabetes Study found that SMBG was not independently associated with improved survival, and there were inconsistent findings relating to the association of SMBG with cardiac death and retinopathy.…”

mentioning

confidence: 99%

Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group

Czupryniak

Barkai

Bolgarska³

et al. 2014

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

Self-monitoring of blood glucose (SMBG) is universally considered to be an integral part of type 1 diabetes management and crucial for optimizing the safety and efficacy of complex insulin regimens. This extends to type 2 diabetes patients on intensive insulin therapy, and there is also a growing body of evidence suggesting that structured SMBG is beneficial for all type 2 diabetes patients, regardless of therapy. However, access to SMBG can be limited in many countries in Central and Eastern Europe. A consensus group of diabetes experts from 10 countries in this region (with overlapping historical, political, and social environments)-Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia, and Ukraine-was formed to discuss the role of SMBG across the spectrum of patients with diabetes. The group considered SMBG to be an essential tool that should be accessible to all patients with diabetes, including those with non-insulin-treated type 2 diabetes. The current article summarizes the evidence put forward by the consensus group and provides their recommendations for the appropriate use of SMBG as part of individualized patient management. The ultimate goal of these evidence-based recommendations is to help patients and providers in Central and Eastern Europe to make optimal use of SMBG in order to maximize the efficacy and safety of glucose-lowering therapies, to prevent complications, and to empower the patient to play a more active role in the management of their diabetes.

show abstract

“…Barnett et al 37 and Polonsky et al 38 reported that the SMBG/education combination led to significantly greater reductions in A1C than education alone. Ezenwaka et al 35 reported that the combination led to significantly greater decreases in A1C than usual care. The results of Kleefstra et al 36 were less clear.…”

Section: Resultsmentioning

confidence: 99%

“…Many studies did not examine moderators. 35,37,39,40,42,44 Farmer et al 46 and Polonsky et al 38 investigated medication as a possible moderator and found that it did not affect the relationship between SMBG and A1C, nor did BMI, 36 duration of diabetes, 36,46 health status, or complications. 46 Kleefstra et al 36 found adherence to self-management intervention procedures unrelated to outcomes, but 2 studies indicated treatment adherence as a potential moderator, 39,43 echoing Surgeon General Koop’s statement that “[treatments] don’t work in patients who don’t [use] them.” 47…”

Section: Resultsmentioning

confidence: 99%

Using the Common Sense Model of Self-Regulation to Review the Effects of Self-Monitoring of Blood Glucose on Glycemic Control for Non–Insulin-Treated Adults With Type 2 Diabetes

et al. 2013

View full text Add to dashboard Cite

show abstract

Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago

Abstract: Provision of facilities for self-monitoring of blood glucose in Afro-Caribbean women with type 2 diabetes improves both their glycemic control and CHD risk profile.

Cited by 11 publications

References 31 publications

Hepatitis B virus and HIV co-infection among pregnant women in Rwanda

Hepatitis B virus and HIV co-infection among pregnant women in Rwanda

Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group

Using the Common Sense Model of Self-Regulation to Review the Effects of Self-Monitoring of Blood Glucose on Glycemic Control for Non–Insulin-Treated Adults With Type 2 Diabetes

Contact Info

Product

Resources

About